A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects

NCT01911741 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Castration Resistant Prostate Cancer (CRPC)
Relative Bioavailability
MDV3100

Interventions

DRUG: MDV3100

Sponsor

Astellas Pharma Europe B.V.

Collaborators

[object Object]